Metastatic colorectal cancer patients treated first-line with SIR-spheres Y-90 resin microspheres more likely to become candidates for potentially curative liver surgery, the REsect study shows.
Sirtex has announced the presentation of the SIRFLOX/FOXFIRE Global right-side survival data in metastatic colorectal cancer at the 19th European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer (WCGIC) in Barcelona, Spain.
Siemens Healthineers has received the CE mark for the 7 Tesla magnetic resonance (MR) scanner Magnetom Terra, making it the first-ever ultra-high-field MR scanner to be approved for clinical use, a press release from the company says.
According to a new study published online in the journal Radiology, when ultrasound-guided percutaneous irrigation is performed to treat shoulder calcification, the choice of using either one needle or two should be tailored to the type of calcification.
The Society of Interventional Oncology (SIO and BTG have announced their 2017 Interventional interventional oncology /immuno-oncology research grant recipients.
The Society of Interventional Radiology and its Women in Interventional Radiology section have issued a position statement to support interventional radiologists who choose to become parents. The statement was published in the July issue of SIR’s Journal of Vascular and Interventional Radiology (JVIR).
The FOXFIRE, SIRFLOX and FOXFIRE Global randomised studies evaluated the efficacy of combining first-line chemotherapy for metastatic colorectal cancer with selective internal radiotherapy (SIRT) using yttrium-90 resin microspheres (SIR-Spheres, Sirtex) in patients with liver metastases. The combined FOXFIRE analysis comprises data from the SIRFLOX study, first presented in 2015, and data from two new studies – FOXFIRE and FOXFIRE Global.
SIRveNIB is an investigator-led Asia Pacific Primary Liver Cancer Study to be presented on 4 June 2017 at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, USA.
Spectranetics has announced receipt of US Food and Drug Administration (FDA) premarket approval of the Stellarex drug-coated balloon (DCB), designed to restore and maintain blood flow to the superficial femoral and popliteal arteries in patients with peripheral artery disease (PAD).
The Society of Interventional Oncology (SIO) has announced new officers and a Board of Directors.
The treatment can help restore fertility in women with uterine fibroids, according to a new study published online in the journal Radiology.
TVA Medical has announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQ endoAVF system. The 12-month data published online in the American Journal of Kidney Diseases (AJKD) demonstrate the potential benefit of the novel approach to create haemodialysis access as an alternative to traditional open surgery.
The UK’s Information Commissioner’s Office (ICO) has found that the Royal Free National Health Service (NHS) Foundation Trust (London, UK) did not adhere to the UK’s Data Protection Act when it provided patient details to Google DeepMind.
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has announced the presentation of the second edition of the European Curriculum and Syllabus for Interventional Radiology.
A session at the World Conference on Interventional Oncology (WCIO; 8–11 June, Boston, USA), organised by the Society of Interventional Oncology (SIO), identified the most influential publications of 2016–17. The session was moderated by Muneeb Ahmed (Beth Israel Deaconess Medical Center, Boston, USA) and David C Madoff (Weill Cornell Medical Center, New York, USA).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos